Open registration: poorly soluble drug candidates and the SprāSol® platform, with Zeren Wang, November 14
Episode 5 of NAPPA Healthcare & Biopharma Insights follows difficult molecules from developability assessment to clinical translation.
NAPPA’s thought-leadership webinar series — NAPPA Healthcare & Biopharma Insights — continues on Saturday, November 14, 2026, 9:00–10:00 PM ET with Episode 5: From Developability Assessment to Clinical Translation: Enabling Poorly Soluble Drug Candidates with the SprāSol® Platform.
The episode is led by Dr. Zeren Wang, Co-founder, Chairman and Chief Scientific Officer of Pharmacin. He presents the SprāSol® platform for poorly soluble and complex drug candidates, and the path from early developability assessment to the clinic.
What’s covered
- The SprāSol® platform for poorly soluble and complex drug candidates
- Developability assessment early in a program
- Carrying a candidate from assessment to clinical translation
- Where solubility decides whether a candidate advances
Register
Registration is free for NAPPA members and qualified industry guests. Seats are limited; join details are sent by email after registering.